|
2 Companies |
|
1 Product |
|
1 Product |
|
3 Mechanisms of Action |
|
0 Trials |
|
7 News |
|
- | Enrollment change: Disc Edema in Patients With Chronic Kidney Disease (clinicaltrials.gov) - Feb 28, 2018
P=N/A, N=0, Withdrawn, Sponsor: University of Mississippi Medical Center
N=323 --> 0
- Kineret (anakinra) / SOBI
Trial suspension: Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=70, Suspended, Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
N=323 --> 0 Recruiting --> Suspended
- Kineret (anakinra) / SOBI
Enrollment change, Trial suspension: Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=70, Suspended, Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting --> Suspended N=900 --> 70 | Recruiting --> Suspended
- acetazolamide / Generic mfg.
Trial primary completion date: IIHTT: Idiopathic Intracranial Hypertension Treatment Trial (clinicaltrials.gov) - May 12, 2014
P2/3, N=166, Completed, Sponsor: St. Luke's-Roosevelt Hospital Center
N=900 --> 70 | Recruiting --> Suspended Trial primary completion date: Nov 2012 --> Jun 2013
- | acetazolamide / Generic mfg.
Trial completion: IIHTT: Idiopathic Intracranial Hypertension Treatment Trial (clinicaltrials.gov) - May 12, 2014
P2/3, N=166, Completed, Sponsor: St. Luke's-Roosevelt Hospital Center
Trial primary completion date: Nov 2012 --> Jun 2013 Active, not recruiting --> Completed
- | acetazolamide / Generic mfg.
Enrollment closed: IIHTT: Idiopathic Intracranial Hypertension Treatment Trial (clinicaltrials.gov) - Dec 10, 2012
P2/3, N=154, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting